51
video
Addressing Social Determinants to Improve Health Outcomes
Health is not only determined by biology, genetics, and individual behaviors, but is also largely
impacted by social and physical environments, including resource availability and the communities in which individuals reside.
+ Read More
video
Partnerships in Global Health
Partnerships can be the key to advancing global health innovation by providing increased expertise
through multi-stakeholder collaboration, greater opportunities for scale through expanded reach, and further mechanisms to bridge looming financial gaps.
+ Read More
video
A Conversation with Ben Carson, Secretary, U.S. Department of Housing and Urban Development
This session will open with a conversation with Ben Carson, Secretary, U.S. Department of Housing
and Urban Development, followed by a panel discussion.
+ Read More
video
Food is Medicine
We are in the midst of a food revolution fueled by shifting consumer preferences, emerging nutriti
on science, geopolitical shifts and health crises.
+ Read More
video
The Shifting Sands of Market Structure: Equity Trading in the Spotlight
Now that the media euphoria from Flash Boys has died down and the pillars of U.S. equity markets a
re no longer being called into question, constructive conversations about addressing market fairness and inefficiencies have begun to take shape.
+ Read More
video
After Ebola and Zika: Preparing for the Next Pandemic
Moderator: Cristina Alesci
Speakers: Anthony Banbury, Dara Erck, Raul Ruiz, Rajeev Venkayya
video
System Thinking to Drive Patient Engagement: Walking the Talk
The first chief patient officer role was created in 2014, and since then, biopharmaceutical compan
ies have created similar positions, restructured teams, and convened internal meetings to advance patient engagement and patient-centered practices through
+ Read More
video
Confronting the Obesity and Diabetes Epidemics
An estimated 30.3 million people in the U.S. have diabetes, or 9.4% of the population. In 2017, th
e costs of diagnosed diabetes totaled $327 billion, including $237 billion in health care costs and $90 billion in reduced productivity.
+ Read More
video
Regulating Medical Innovation in the Digital Age
Over the last decade, the Food and Drug Administration has worked hard to take a more nimble appro
ach to regulation, increase the number of approvals, prioritize truly innovative products, and integrate patient perspective into its evaluations.
+ Read More
video
A Conversation with Scott Gottlieb, Commissioner, U.S. Food and Drug Administration
This closing session will begin with a conversation with Scott Gottlieb, Commissioner, U.S. Food a
nd Drug Administration, moderated by FasterCures' Tanisha Carino.
+ Read More
video
A Conversation with Dan Gilbert
Join Dan Gilbert, founder and chairman of Quicken Loans and Rock Ventures, and majority owner of t
he NBA Cleveland Cavaliers, as he discusses his philanthropic journey, from curing rare disease to revitalizing his hometown of Detroit.
+ Read More
video
Creating a Culture of Biomedical Innovation
Over the past decade, business courses, magazines, and media outlets have overflowed with advice a
nd research on how companies can "create a culture of innovation." Recommendations such as embrace failure, eliminate hierarchy, be transparent, and promot
+ Read More